BlackThorn Therapeutics

BlackThorn Therapeutics

BlackThorn Therapeutics

BlackThorn Therapeutics is a clinicalstage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments.
Founded
2014
Raised
$14M
Follow us
Alexa global traffic share
Latest funding
$14,000,000
Venture capital (Series A) - 2017
GV Biomatics Capital
Team Size
10+
Employees
the home of AI info

BlackThorn Therapeutics Reports New Insights into Neurobehavioral Disorders at the 49

$14,000,000 Venture capital (Series A)
businesswire

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing | Business Wire

$40,000,000 Venture capital (Series A)
FinSMEs

BlackThorn Therapeutics Secures $40M Series A Funding

Funding Science